Article ; Online: COVID-19 Pandemic and Thalassemia Major Patients: Transfusion Practice and Treatment Assessment.
Journal of pediatric hematology/oncology
2020 Volume 43, Issue 8, Page(s) e1073–e1076
Abstract: Background: When the COVID-19 epidemic occurred for the first time in December 2019, the governments worldwide took some restriction measures for slowing the spread of novel coronavirus. Eventually, there was a considerable decrease in volunteer blood ... ...
| Abstract | Background: When the COVID-19 epidemic occurred for the first time in December 2019, the governments worldwide took some restriction measures for slowing the spread of novel coronavirus. Eventually, there was a considerable decrease in volunteer blood donations. Regular transfusions and follow-up of patients with thalassemia major (TM) should be maintained during this period. It is possible that the treatment of the patients with TM may hinder due to the difficulty of reaching the treatment center and the difficulty of blood supply. Thus, in this study, we aimed to investigate whether there were any differences in the follow-up and treatment of the patients with TM during the outbreak. Materials and methods: Sixty-one patients with TM who were followed up in our center without COVID-19 contact history and symptoms were included in this study. The demographic features and red blood cell volume per kilogram they received, pretransfusion hemoglobin, serum ferritin (SF) level, biochemical parameters, and transfusion interval were recorded. The difference between the arithmetic mean of the data before and during the pandemic was evaluated. Results: In this study, 61 patients with TM (32 males/29 females, mean age 13.9±6.8 y) were evaluated. The mean pretransfusion hemoglobin value was 9.14±0.77 g/dL and 8.87± 0.80 g/dL before and during the pandemic, respectively (P=0.023). There was no difference between before and during the pandemic concerning transfusion interval and transfusion volume. However, SF levels increased above 1000 ng/mL in 16.6% of patients. Conclusion: Although blood donation decreased significantly during the pandemic, it was observed in this study that the blood needs of patients with TM could be provided. The results of the SF level showed that the management of chelation therapy should be more meticulous. However, we should be ready for the challenges in the transfusion practice of patients with TM due to fluctuations in the COVID-19 pandemic. |
|---|---|
| MeSH term(s) | Adolescent ; Blood Donors/supply & distribution ; Blood Transfusion/statistics & numerical data ; COVID-19/epidemiology ; COVID-19/virology ; Continuity of Patient Care/statistics & numerical data ; Female ; Health Services Accessibility ; Humans ; Male ; Patient Acceptance of Health Care ; Patient Compliance ; Practice Patterns, Physicians'/standards ; SARS-CoV-2/isolation & purification ; Turkey/epidemiology ; beta-Thalassemia/pathology ; beta-Thalassemia/therapy |
| Language | English |
| Publishing date | 2020-12-03 |
| Publishing country | United States |
| Document type | Journal Article |
| ZDB-ID | 1231152-2 |
| ISSN | 1536-3678 ; 1077-4114 ; 0192-8562 |
| ISSN (online) | 1536-3678 |
| ISSN | 1077-4114 ; 0192-8562 |
| DOI | 10.1097/MPH.0000000000002016 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 1537: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.